4.2 Article

Oncostatin M and its receptor in women with polycystic ovary syndrome and association with assisted reproductive technology outcomes

Journal

REPRODUCTIVE BIOLOGY
Volume 22, Issue 2, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.repbio.2022.100633

Keywords

Follicular fluid; Oncostatin M; Oocyte maturation; Polycystic ovary syndrome

Funding

  1. Stem Cell Research Center of Tabriz University of Medical Sciences [62615]

Ask authors/readers for more resources

This study found that the levels of OSM and OSMR in the follicular fluid of PCOS patients were lower, possibly mediated by SOCS3, which could negatively affect oocyte maturation and fertilization rates.
The role of adipokines in ovarian-related disorders such as polycystic ovary syndrome (PCOS) has been reported. However, the involvement of Oncostatin M (OSM), a recently identified adipokine, in ovarian function is unknown. Therefore, we investigated the association of the OSM signaling pathway with ovarian functions and PCOS pathogenesis. This case-control study enrolled 30 PCOS and 30 healthy women who underwent the intracytoplasmic sperm injection procedure. OSM and OSM receptor (OSMR) levels were evaluated in the follicular fluid (FF). Moreover, the expression of insulin receptor substrates (IRS1 and IRS2), OSM, OSMR, suppressor of cytokine signaling 3 (SOCS3), and androgen receptor (AR) genes were analyzed in the isolated cumulus cells (CCs). For the in-vitro experiment, the effect of recombinant OSM on the expression of related genes in isolated CCs was analyzed. Follicular concentrations of OSM and OSMR were significantly lower in PCOS (123.91 +/- 48.58 pg/ml and 0.93 +/- 0.35 ng/ml, respectively) compared to control women (283.53 +/- 96.62 pg/ ml and 1.45 +/- 0.18 ng/ml, respectively; p < 0.001) and were positively correlated with the oocyte maturation (r = 0.611 and r = 0.611, respectively) and fertilization (r = 0.592 and r = 0.627, respectively) rates in the PCOS group. Furthermore, the SOCS3 expression was upregulated about eight times in PCOS patients compared to the controls (p < 0.05). The treatment of cells with recombinant OSM significantly increased SOCS3, OSMR, IRS-1, and-2 expression and decreased AR expression. The decreased levels of OSM and its receptor in PCOS patients, possibly mediated by SOCS3, could negatively affect oocyte maturation and fertilization rates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available